MHHi018-A

Registration Summary:

A P E C

CF19 iPSC9

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	MHHi018-A
Cite as:	MHHi018-A (RRID:CVCL_YX91)
Alternative name(s)	CF19 iPSC9
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	15th January 2020
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Hannover Medical School (MHH)
External iPSC Databases
Cellosaurus	CVCL_YX91
Wikidata	Q95989481
General iPSC Information
Publications	Merkert S et al. Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation. Stem cell research. 2020 Apr;44:101744. Kloos D et al. Generation of Human iPSC from Small Volume Peripheral Blood Samples. Methods in molecular biology (Clifton, N.J.). 2022;2429:27-39. Moreira A et al. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells. Advanced biology. 2022 Feb;6(2):e2101139. Cheng Wei et al. Induced pluripotent stem cell-based therapies for organ fibrosis. Frontiers in Bioengineering and Biotechnology. 2023-05-18. von Schledorn L et al. Primary Ciliary Dyskinesia Patient-Specific hiPSC-Derived Airway Epithelium in Air-Liquid Interface Culture Recapitulates Disease Specific Phenotypes In Vitro. Cells. 2023 May 24;12(11). Parvatam Surat et al. Human-based complex in vitro models: their promise and potential for rare disease therapeutics. Frontiers in Cell and Developmental Biology. 2025-01-27. Birch Camille L. et al. Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation. Journal of Translational Medicine. 2025-12-24.

iPSC Derivation

General